Oral Formulation II Protein-based Tablet

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral Formulation II Protein-based Tablet, covering 2024-07-12 to 2024-07-12. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II [Phase 1]